Clinical Trial Update: CD45BE-HSPC + CART-45 Cells [Phase 1]

View source ↗

Summary

Phase 1 study evaluating CD45BE-HSPC with CART-45 cells is not yet recruiting and targets B-cell non-Hodgkin lymphoma and Richter transformation. The study is s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Hodgkin Lymphoma
• Richter Transformation
• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• CART-45 Cells
• CD45BE-HSPC

Snippet

Sponsor: University of Pennsylvania | Conditions: B-Cell Non-Hodgkin Lymphoma (NHL), Richter's Transformation | Phase 1 | Status: NOT_YET_RECRUITING